Oryzon Genomics SA ORYZF
$3.36 $0.06 (1.82%) 1D
Last Updated: Aug 14, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
ORYZF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Oryzon Genomics SA is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Oryzon Genomics SA. Stock Analysis ORYZF
United States Health Care Micro Cap Oryzon Genomics SA is a clinical stage biopharmaceutical company, which engages in the discovery, research, and development of new chemical entities, as well as conducting clinical trials. The company employs 44 full-time employees The company went IPO on 2015-12-10. Its compounds in clinical development include iadademstat (ORY-lOOl), an LSD1 inhibitor that is in Phase II trials for the treatment of acute myeloid leukemia and small cell lung cancer; and vafidemstat (ORY-2001), an LSD1 inhibitor optimized for the Central Nervous System (CNS), in multiple Phase II clinical trials for the treatment of CNS and psychiatric illnesses. The firm also has ORY-3001, in preclinical development for the treatment of non-oncological diseases and has additional programs to develop inhibitors against other epigenetic targets.
Oryzon Genomics SA (ORYZF) Chart
Financial Metrics & Statements of Oryzon Genomics SA (ORYZF)
FAQ's for Oryzon Genomics SA (ORYZF)
- As of August 2026, Oryzon Genomics SA ORYZF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Oryzon Genomics SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Oryzon Genomics SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Oryzon Genomics SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Oryzon Genomics SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Oryzon Genomics SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Oryzon Genomics SA (ORYZF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
